Amarin News

European Equities Traded in the US as American Depositary Receipts Kick Off Week Higher

European equities traded in the US as American depositary receipts kicked off the week higher in Monday morning, rising 0.62% to 1,421.16 on the S&P Europe Select ADR Index. From continental Europe, t

MT NewswiresMay 13 10:12

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%

European equities traded in the US as American depositary receipts were trending higher late Friday morning, rising 0.60 to 1,414.50 on the S&P Europe Select ADR Index. With the gain, the index is poi

MT NewswiresMay 10 10:13

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading

European equities traded in the US as American depositary receipts were trending modestly higher late Wednesday morning, rising 0.34% to 1,399.71 on the S&P Europe Select ADR Index. From continental E

MT NewswiresMay 8 10:26

Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday

Bank stocks helped European equities traded in the US as American depositary receipts higher late Tuesday morning, rising 0.77% to 1,396.19 on the S&P Europe Select ADR Index. From continental Europe,

MT NewswiresMay 7 10:07

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

European equities traded in the US as American depositary receipts started the week off on a positive note, rising 0.42% to 1,380.39 on the S&P Europe Select ADR Index. From continental Europe, the ga

MT NewswiresMay 6 10:19

Amarin to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference

DUBLIN, Ireland and BRIDGEWATER, N.J., May 06, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Patrick Holt, Amarin's president and chief executive officer, is scheduled to

GlobeNewswireMay 6 07:00

Ventyx Biosciences closed 25.13%, leading Summit Therapeutics Plc. Cabaletta Bio, Wave Life Sciences, Xencor, Humacyte, and BioCryst Pharmaceuticals rose 19.59%-10.65%, and Iteos rose 9.82%; SAGE Therapeutics closed down 4.73%, Tango Therapeutics fell 5.4

Ventyx Biosciences closed 25.13%, leading Summit Therapeutics Plc. , Cabaletta Bio, Wave Life Sciences, Xencor, Humacyte, and BioCryst Pharmaceuticals rose 19.59%-10.65%, iteos rose 9.82%; SAGE Therapeutics closed down 4.73%, Tango Therapeutics fell 5.45%, and Alexis fell 6.54

Zhitong FinanceMay 1 15:55

European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were trending modestly lower Wednesday morning, declining 0.36% to 1,359.56 on the S&P Europe Select ADR Index. From continental Euro

MT NewswiresMay 1 10:39

Amarin's Sell Rating Affirmed Amid US Market Challenges and Uncertain European Growth

TipRanksMay 1 09:25

Amarin Corp PLC (AMRN) Q1 2024 Earnings: Navigating Challenges With Strategic Focus

Yahoo FinanceMay 1 07:35

Earnings Flash (AMRN) AMARIN CORPORATION Posts Q1 Revenue $56.5M

07:07 AM EDT, 05/01/2024 (MT Newswires) -- Earnings Flash (AMRN) AMARIN CORPORATION Posts Q1 Revenue $56.5M

MT NewswiresMay 1 06:07

Amarin Corp Q1 2024 Adj EPS $(0.01) Beats $(0.03) Estimate, Sales $56.519M Miss $57.045M Estimate

Amarin Corp (NASDAQ:AMRN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 150 percent decrease over earnings of $0.02 pe

BenzingaMay 1 06:03

Amarin 1Q Loss/Shr 2c >AMRN

Amarin 1Q Loss/Shr 2c >AMRN

Dow JonesMay 1 06:00

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersAcrivon Therapeutics (NASDAQ:ACRV) stock rose 12.3% to $10.67 during Wednesday's after-market session. The market value of their outstanding shares is at $329.4 million. Amarin Corp (NASDAQ:AMR

BenzingaApr 24 15:31

Amarin Shareholders Show Strong Support at Annual Meeting

TipRanksApr 22 12:12

Amarin Announces Results of Annual General Meeting of Shareholders

Amarin Corporation plc (NASDAQ:AMRN) today announced shareholder approval of all proposed resolutions specified at its 2024 Annual General Meeting (AGM).

GlobeNewswireApr 22 07:00

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down

European equities traded in the US as American depositary receipts were trending higher Friday morning, rising 0.46% to 1,330.20 on the S&P Europe Select ADR Index. Despite the gain, the index remains

MT NewswiresApr 19 10:10

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading

European equities traded in the US as American depositary receipts were treading water in Thursday morning session, nudging 0.006% higher to 1,330.06 on the S&P Europe Select ADR Index. From continent

MT NewswiresApr 18 10:08

Amarin to Report First Quarter 2024 Financial Results and Host Conference Call on May 1, 2024

DUBLIN, Ireland and BRIDGEWATER, N.J., April 15, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Patrick Holt, President & CEO,

GlobeNewswireApr 15 07:00

323 drugs, hurry up! America is facing the biggest “drug shortage” in history...

The US now seems to be facing an unprecedented “drug shortage”...

cls.cnApr 15 01:37